Specifically, a greater percentage of those with high IL-6 also had raised PD-L1 expression levels and subsequently experienced poorer OS, as observed in our ESCC tissue microarray immunohistochemistry results. This evidence concerns the gene IL6 and esophageal squamous cell carcinoma.